MannKind completes phase 1 trial of nintedanib DPI for pulmonary fibrotic diseases: Danbury, Connecticut Tuesday, November 5, 2024, 16:00 Hrs [IST] MannKind Corporation, a company ...

Cordyceps, a fungus that grows on caterpillar larvae, has been used for centuries in traditional Chinese medicine (TCM) to ...

A study of 7 million medical records found that in Australia, patients with long COVID are more likely to be women than men, ...

According to Dr. Dibyendu Mukherjee, Director, Internal Medicine ... cough, which can be very severe in older persons.

Proceeds expected to support the upcoming planned launches and fund the continued development of Niktimvo and revumenibExpected to fund Syndax ...

Identifying the underlying causes of prolonged lung inflammation associated with radiographic abnormalities could be key understanding long COVID and other lung conditions, researchers say.

The Crown Prince and Princess (left) were informed in advance that their stepson and son was going to be arrested following ...

Regular monitoring of AQI levels, coupled with precautionary measures, such as protecting health, especially during peak pollution seasons, would allow individuals to continue their daily activities ...

Syndax Pharmaceuticals and Royalty Pharma plc today announced that Syndax has entered into a $350 million synthetic royalty funding agreement with Royalty Pharma based on U.S. net sales ...

I've been offered an operation to remove a prolapsed haemorrhoid but I'm worried it will be painful and leave me incontinent.

Proceeds expected to support the upcoming planned launches and fund the continued development of Niktimvo and revumenibExpected to fund Syndax through profitability; proforma cash approaching $800 mil ...